Process Development and Pilot-Plant Synthesis of (2-Chlorophenyl)[2-(phenylsulfonyl)pyridin-3-yl]methanone

Michael E. Kopach; Michael E. Kobierski; D. Scott Coffey; Charles A. Alt; TONY ZHANG; Alfio Borghese; William G. Trankle; Dilwyn J. Roberts; Humphrey Moynihan; Kurt Lorenz; Orla A. McNamara; Marie Kissane; Anita R. Maguire

doi:10.1021/op100157q

journal article Aug 31, 2010

Process Development and Pilot-Plant Synthesis of (2-Chlorophenyl)[2-(phenylsulfonyl)pyridin-3-yl]methanone

Michael E. Kopach Michael E. Kobierski D. Scott Coffey Charles A. Alt TONY ZHANG Alfio Borghese William G. Trankle Dilwyn J. Roberts Humphrey Moynihan Kurt Lorenz Orla A. McNamara Marie Kissane Anita R. Maguire

Organic Process Research & Development Vol. 14 No. 5 pp. 1229-1238 · American Chemical Society (ACS)

View at Publisher Save 10.1021/op100157q

Topics

No keywords indexed for this article. Browse by subject →

References

44

[1]

Kramer M. S. Science. (1998) 10.1126/science.281.5383.1640

[2]

Kramer M. S. Neuropsychopharmacology (2004) 10.1038/sj.npp.1300260

[3]

Timpe, C.; Borghese, A.; Coffey, S. D.; Footman, P. K.; Pedersen, S. W.; Reutzel-Edens, S. M.; Tameze, S. L.; Weber, C.WO/2005/042515, 2005.

[4]

CAN 142:469259.

[5]

Process mass intensity is defined as the total mass of all materials (kg) used to produce 1 kg of active pharmaceutical ingredient (API). The process mass intensity calculation is based on compound1. For leading references see:

[6]

Dunn P. J. (2010) 10.1002/9783527629688

[7]

Constable D. J. C. Green Chem. (2002) 10.1039/b206169b

[8]

Constable D. J. C. Green Chem. (2001) 10.1039/b007875l

[9]

Eissen M. Green Chem. (2003) 10.1039/b301753m

[10]

Backvall J. E. (2004) 10.1002/3527603689

[11]

Zanka A. Chem. Pharm. Bull. (2003) 10.1248/cpb.51.888

[12]

Fritz-Langhals E. Org. Process Res. Dev. (2005) 10.1021/op050040t

[13]

Rossi F. Org. Process Res. Dev. (2008) 10.1021/op7001112

[14]

Hewitt, B. D.WO/1995/9516698, 1995.

[15]

CAN 123:314263.

[16]

2010 Aldrich pricing = $6/g (25 g quantity).

[17]

Rawalpally T. Org. Process Res. Dev. (2008) 10.1021/op8001596

[18]

Hickey R. M. Org. Process Res. Dev. (2005) 10.1021/op0501444

[19]

Bridges A. J. Tetrahedron Lett. (1992) 10.1016/s0040-4039(00)60805-5

[20]

In the event of a catastrophic utilities failure the process energetics are not sufficient to bring the reactor temperature up to the boiling point of the solvent system (THF/hexanes) used for the lithiation chemistry.

[21]

Posner G. H. J. Am. Chem. Soc. (1979) 10.1021/ja00498a023

[22]

Grieco P. A. J. Am. Chem. Soc. (1977) 10.1021/ja00459a039

[23]

Enders D. Org. Synth. (1978) 10.15227/orgsyn.058.0113

[24]

Pre-cooling of solutions containing2is not recommended due to precipitation risk.

[25]

In this case, the scale-up runs were performed withn-butyllithium which had been used for several prior experiments.

[26]

Dezmelyk E. W. Ind. Eng. Chem. (1961) 10.1021/ie50618a011

[27]

Schwindeman J. A. Chem. Health Saf. (2002) 10.1016/s1074-9098(02)00295-2

[28]

Commercial LDA is nonpyrophoric, as determined by the Department of Transportation (DOT). The official test for pyrophoricity is detailed in the DOT regulations.Code of Federal Regulations,49 CFR 173, Appendix E.

[29]

Smith I. H. Org. Process Res. Dev. (2003) 10.1021/op0340762

[30]

Collum D. B. J. Org. Chem. (2009) 10.1021/jo802713y

[31]

Morrison, R. C.; Hall, R. W.; Rathman, T. L.U.S. Pat. 4,595,779, 1986.

[32]

Anelli P. L. J. Org. Chem. (1987) 10.1021/jo00388a038

[33]

Anelli P. L. J. Org. Chem. (1989) 10.1021/jo00273a038

[34]

Shibuya M. J. Am. Chem. Soc. (2006) 10.1021/ja0620336

[35]

Criminna R. Org. Process Res. Dev. (2010) 10.1021/op900059x

[36]

Prakash, I.; Tanielyan, S. K.; Augustine, R. L.; Furlong, K. E.; Scherm, R. C.; Jackson, H. E.U.S. Pat. 6,825,384, 2004.

[37]

CAN 142:6014.

[38]

Tanielyan, S. K.; Augustine, R. L.; Prakash, I.; Furlong, K. E.; Scherm, R. C.; Jackson, H. E.WO/2004/067484, 2004.

[39]

CAN 141: 190314.

[40]

Tanielyan, S.; Augustine, R.; Meyer, O.; Korell, M.U.S. Pat. 7,030,279, 2006.

[41]

CAN 144: 393182.

[42]

Preliminary experiments indicate that 2-methyl THF may be a viable alternative to THF for the lithiation chemistry.

[43]

When running the oxidation step in the clinical pilot plant in 2005, AZADO was not available.

[44]

Kopach M. E. Org. Process Res. Dev. (2007) 10.1021/op700060e

Metrics

11

Citations

44

References

Details

Published: Aug 31, 2010
Vol/Issue: 14(5)
Pages: 1229-1238

Authors

M

Michael E. Kopach

Contribution from the Department of Chemistry, University of Virginia, Charlottesville, Virginia 22901

Cite This Article

Michael E. Kopach, Michael E. Kobierski, D. Scott Coffey, et al. (2010). Process Development and Pilot-Plant Synthesis of (2-Chlorophenyl)[2-(phenylsulfonyl)pyridin-3-yl]methanone. Organic Process Research & Development, 14(5), 1229-1238. https://doi.org/10.1021/op100157q

Process Development and Pilot-Plant Synthesis of (2-Chlorophenyl)[2-(phenylsulfonyl)pyridin-3-yl]methanone

You May Also Like